5-[4-[(2S,5S,11S,14R)-14-Benzyl-11-(Carboxymethyl)-5-[3-(Diaminomethylideneamino)Propyl]-3,6,9,12,15-Pentaoxo-1,4,7,10,13-Pentazacyclopentadec-2-Yl]Butylamino]-2-[4,7-Bis(Carboxymethyl)-1,4,7-Triazonan-1-Yl]-5-Oxopentanoic Acid Radioallebled With Gallium-68

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

1 Countries

Phase II

Phase II: 1

Sponsors using this IMP

Centre Hospitalier Regional De Marseille 1

All trials

1 total

Molecular imaging exploration of ocular angiogenic activity and evaluation of its value in therapeutic follow-up of AMD patients Ended

2024-516970-31-00 Phase II 1 country Centre Hospitalier Regional De Marseille

Showing 1–1 of 1 trials

← All drugs A–Z